|
Report Date : |
20.07.2013 |
IDENTIFICATION DETAILS
|
Name : |
DIFFUCAP CHEMOBRAS QUIMICA E FARMACEUTICA LTDA |
|
|
|
|
Registered Office : |
Rua Goias,1232 / 1236 - Quintino Bocaiuva 21380-010 - Rio De Janeiro/Rj |
|
|
|
|
Country : |
Brazil |
|
|
|
|
Date of Incorporation : |
04.03.1975 |
|
|
|
|
Legal Form : |
Limited Liability Company |
|
|
|
|
Line of Business : |
Manufacture and Trade of Pharmaceutical Products. |
|
|
|
|
No. of Employees : |
150 |
RATING & COMMENTS
|
MIRA’s Rating : |
B |
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively
below average. |
Small |
|
Maximum Credit Limit: |
-- |
|
Status : |
Moderate |
|
Payment Behaviour : |
Unknown |
|
Litigation : |
Clear |
NOTES :
Any query related to this report can be made
on e-mail: infodept@mirainform.com
while quoting report number, name and date.
ECGC Country Risk Classification List – March 31st, 2013
|
Country Name |
Previous Rating (31.12.2012) |
Current Rating (31.03.2013) |
|
Brazil |
A2 |
A2 |
|
Risk Category |
ECGC
Classification |
|
Insignificant |
A1 |
|
Low |
A2 |
|
Moderate |
B1 |
|
High |
B2 |
|
Very High |
C1 |
|
Restricted |
C2 |
|
Off-credit |
D |
BRAZIL - ECONOMIC OVERVIEW
Characterized by large and well-developed agricultural,
mining, manufacturing, and service sectors, Brazil's economy outweighs that of
all other South American countries, and Brazil is expanding its presence in
world markets. Since 2003, Brazil has steadily improved its macroeconomic
stability, building up foreign reserves, and reducing its debt profile by
shifting its debt burden toward real denominated and domestically held
instruments. In 2008, Brazil became a net external creditor and two ratings
agencies awarded investment grade status to its debt. After strong growth in
2007 and 2008, the onset of the global financial crisis hit Brazil in 2008.
Brazil experienced two quarters of recession, as global demand for Brazil's commodity-based
exports dwindled and external credit dried up. However, Brazil was one of the
first emerging markets to begin a recovery. In 2010, consumer and investor
confidence revived and GDP growth reached 7.5%, the highest growth rate in the
past 25 years. Rising inflation led the authorities to take measures to cool
the economy; these actions and the deteriorating international economic
situation slowed growth to 2.7% in 2011, and 1.3% in 2012. Unemployment is at
historic lows and Brazil's traditionally high level of income inequality has
declined for each of the last 14 years. Brazil's historically high interest
rates have made it an attractive destination for foreign investors. Large
capital inflows over the past several years have contributed to the appreciation
of the currency, hurting the competitiveness of Brazilian manufacturing and
leading the government to intervene in foreign exchange markets and raise taxes
on some foreign capital inflows. President Dilma ROUSSEFF has retained the
previous administration's commitment to inflation targeting by the central
bank, a floating exchange rate, and fiscal restraint. In an effort to boost
growth, in 2012 the administration implemented a somewhat more expansionary
monetary policy that has failed to stimulate much growth
Source
: CIA
DIFFUCAP CHEMOBRAS QUIMICA E FARMACEUTICA LTDA
|
MAIN ADDRESS: |
RUA GOIAS,1232 / 1236 - QUINTINO BOCAIUVA |
|
ZIP CODE/CITY: |
21380-010 - RIO DE JANEIRO/RJ |
|
|
|
|
PHONE: |
21 3508-3500 |
|
FAX: |
21 3508-3500 |
|
E-MAIL: |
contabiliadade@diffucap.com.br |
|
WEB SITE: |
www.diffucap.com.br |
|
BRANCHES: |
|
NOT AVAILABLE. |
|
MAIN ACTIVITIES: |
|
MANUFACTURE AND TRADE OF PHARMACEUTICAL PRODUCTS. |
|
LEGAL FORM: |
LIMITED
LIABILITY COMPANY |
|
|
|
|
INCORPORATION DATE: |
04/03/1975 |
|
REGISTER DATE: |
30/04/1975 |
|
BALANCE SHEET FILING DATE: |
31/12 |
|
TAX CONTRIBUTOR NUMBER(CNPJ): |
42.457.796/0001-56 |
|
STATE REGISTER: |
81.726.094 |
|
|
|
|
SHARE CAPITAL: |
R$ 1.256.744,00 |
|
BOARD OF
DIRECTORS: |
|
|
|
|
|
RODOLFO TSANGOS PAPASTAWRIDIS |
DIRECTOR |
|
JORGE SAUL DOCTOROVICH |
DIRECTOR |
|
FERANANDO PIPPO KATZBACH |
DIRECTOR |
|
VANIA LOUISE GRANAFEI IFF |
DIRECTOR |
|
THE DIRECTORS ARE AUTHORIZED TO SIGN ON BEHALF OF THE COMPANY. |
|
SHAREHOLDERS /
PARTNERS: |
|
|
|
|
|
BLADOSTIL SOCIEDADE ANONIMA |
R$ 936.274,00 |
|
ASTOKIL INVERSORA SOCIEDADE ANONIMA |
R$ 320.469,72 |
|
AFFILIATES /
SUBSIDIARIES: |
|
|
|
|
|
NOT AVAILABLE. |
|
|
THE SUBJECT WAS ESTABLISHED ON MARCH 04, 1975 AS DIFFUCAP QUÍMICA E
FARMACEUTICA LTDA,. TO BE ENGAGED IN THE SAID LINE OF BUSINESS. ON SEPTEMBER 30,
1996 IT ADOPTED THE ABOVE MENTIONED NAME AND UP TO DATE IT IS STILL OPERATING
WITHIN THE GENERAL SCENE REPORTED HEREIN. THE COMPANY OPERATES WITH THE TRADE NAME OF "DIFFUCAP
CHEMOBRAS" FURTHER DETAILS ARE SO FAR NOT KNOWN. REMARKS: -------- WHEN INTERVIEWED SOURCES AT THE SUBJECT STATED THAT ARE STILL WAITING
FOR AUTHORIZATION FROM THE PRINCIPALS TO PROVIDE THE DATA NECESSARY TO
COMPLETE THIS REPORT. A REQUEST FOR FURTHER DATA HAS BEEN SENT TO THE COMPANY. PROVIDED THE
DATA REQUESTED ARE RECEIVED FROM THE SUBJECT A COMPLEMENTARY REPORT WILL BE
SENT TO YOUR ATTENTION. THE DATA CONTAINED HEREIN WERE OBTAINED FROM OUTSIDE SOURCES, OUR
DATABASE AND OFFICIAL. NO FURTHER DATA WAS AVAILABLE WITH SEVERAL SOURCES
USUALLY INVESTIGATED. |
|
PUBLIC INFORMATION: |
|
LAWSUITS: |
|
|
|
|
DATE: |
COURT OF LAW: |
|
1 |
STATE LAWSUIT |
07/01/09 |
11ª VARA DE RIO DE JANEIRO/RJ |
|
DUE TO THE SUBJECT'S LEGAL FORM, IT IS NOT OBLIGED TO PUBLISH THE BALANCE
SHEET INFORMATION. WHEN INTERVIEWING SOURCES AT THE SUBJECT COMPANY DECLINED
TO PROVIDE ANY KIND OF FINANCIAL INFORMATION. OUTSIDE SOURCES CONTACTED SHOWED NO FINANCIAL DATA ABOUT THIS COMPANY.
|
|
EXCHANGE RATE: |
|
|
US$ 1,00 = R$ 2,22 |
- OFFICIAL RATE ON 18/07/2013 |
|
COMMENTS ON THE
FINANCIAL INFORMATION: |
|
IN THE ABSENCE OF FINANCIAL INFORMATION NO COMMENTS CAN BE MADE ABOUT
THE SUBJECT'S CURRENT FINANCIAL STANDING. |
|
REAL ESTATE: |
NOT AVAILABLE
|
VEHICLES: |
NOT AVAILABLE
|
MACHINES: |
NOT AVAILABLE
|
NOT AVAILABLE. |
|
|
|
|
|
NOT AVAILABLE. |
|
|
|
REMARKS: IN BRAZIL THE BANKS ARE PROHIBITED BY LAW TO PROVIDE INFORMATION
OR ANY KIND OF COMMENTS ABOUT THEIR CLIENTS. DUE TO THIS LAW PROHIBITION WE
ARE UNABLE TO PROVIDE ANY BANKING DETAILS. ACCORDING TO THE CENTRAL BANK OF BRAZIL OFFICIAL REPORT, THE COMPANY
HAS NOT RETURNED CHECKS UP TO DATE. (IN THE TERMS OF "CIRCULAR 1682
BRAZILIAN CENTRAL BANK"). |
|
MANUFACTURE AND TRADE OF PHARMACEUTICAL PRODUCTS. |
|
IMPORT AND
EXPORT: |
IMPORTS FROM:
|
NOT AVAILABLE. |
EXPORTS TO:
|
NOT AVAILABLE. |
|
MAIN CLIENTS: |
|
|
|
|
|
|
|
DOMESTIC
CLIENTS: |
|
|
|
NOT AVAILABLE. |
|
|
|
STAFF: |
|
|
|
THE COMPANY HAS: 150 EMPLOYEE(S) |
|
THE SUBJECT IS AN OLD ESTABLISHED COMPANY, OPERATING SINCE 1975. SO FAR
IT HAS A CLEAR TRADE HISTORY AND MODEST PAYMENT BEHAVIOUR. THE COMPANY HAS TRADE RELATIONS WITH SOME LOCAL SUPPLIERS BUT UP TO
DATE ONLY SMALL PAYMENTS WERE REPORTED AND THE SUBJECT IS NOT SAID TO BE USER
OF TRADE CREDIT FACILITIES. THE LAWSUIT REPORTED IS NOT RELATED WITH TRADE
DEBT. IT IS RELATED TO TAX DEBT THAT FOR ANY REASON THE COMPANY HAS NOT YET
PAID. NEVERTHELESS WE POINT OUT THAT THE SAID LAWSUIT DOES NOT AFFECT THE
COMPANY’S TRADE REPUTATION. |
|
MAIN SUPPLIERS: |
|
|
|
|
|
|
|
DOMESTIC
SUPPLIERS: |
|
|
|
NOT AVAILABLE. |
|
|
|
PAYMENT HISTORY: |
|
1 SUPPLIER REPORTED PAYMENTS: |
|
TOTAL AMOUNT: R$ 4.913,00 |
|
|
|
AMOUNT OF INVOICES PAID: 1 |
|
TOTAL OF PROMPT PAYMENTS: 100% |
|
HIGHEST INVOICE: R$ 4.913,00 |
|
BASED ON THE OVERALL DATA AVAILABLE THE SUBJECT MAY BE CONSIDERED FOR
NORMAL BUSINESS COMMITMENTS. CREDIT FACILITIES HOWEVER SHOULD BE GRANTED ON
FULLY SECURED TERMS ONLY DUE TO THE ABSENCE OF FINANCIAL DATA. |
FOREIGN EXCHANGE RATES
|
Currency |
Unit
|
Indian Rupees |
|
US Dollar |
1 |
Rs.59.79 |
|
|
1 |
Rs.91.03 |
|
Euro |
1 |
Rs.78.52 |
INFORMATION DETAILS
|
Report
Prepared by : |
PRL |
RATING EXPLANATIONS
|
RATING |
STATUS |
PROPOSED CREDIT LINE |
|
|
>86 |
Aaa |
Possesses an extremely sound financial base with the strongest
capability for timely payment of interest and principal sums |
Unlimited |
|
71-85 |
Aa |
Possesses adequate working capital. No caution needed for credit
transaction. It has above average (strong) capability for payment of interest
and principal sums |
Large |
|
56-70 |
A |
Financial & operational base are regarded healthy. General
unfavourable factors will not cause fatal effect. Satisfactory capability for
payment of interest and principal sums |
Fairly Large |
|
41-55 |
Ba |
Overall operation is considered normal. Capable to meet normal
commitments. |
Satisfactory |
|
26-40 |
B |
Capability to overcome financial difficulties seems comparatively below
average. |
Small |
|
11-25 |
Ca |
Adverse factors are apparent. Repayment of interest and principal sums
in default or expected to be in default upon maturity |
Limited with
full security |
|
<10 |
C |
Absolute credit risk exists. Caution needed to be exercised |
Credit not
recommended |
|
-- |
NB |
New Business |
-- |
This score serves as a reference to assess SC’s credit risk and
to set the amount of credit to be extended. It is calculated from a composite
of weighted scores obtained from each of the major sections of this report. The
assessed factors and their relative weights (as indicated through %) are as
follows:
Financial
condition (40%) Ownership
background (20%) Payment
record (10%)
Credit history
(10%) Market trend
(10%) Operational
size (10%)
This report is issued at your request without any
risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL)
or its officials.